Igniting the spark of knowledge
Immunology has been at the forefront of medical research, with interventional trials playing a pivotal role in advancing our understanding and treatment of immune-related conditions. Over the past decade, the landscape of these trials has evolved significantly. Monthly data reveals a steady increase in the number of trials, with a notable 30% rise in completed studies over the last five years. This surge reflects the growing interest and investment in immunology, driven by promising outcomes in primary and secondary measures.
The data highlights the dynamic nature of immunology research, with ongoing trials promising to unlock new therapeutic potentials. As we continue to track these trends, the future of immunology looks promising and transformative.
Total Enrollment in Phase I, II, and III for the Year 2024
Enrollment trend in studies over the years
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Trend of Clinical Trials Over the Last 10 Years
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years
Comparison of Clinical Trials in Canada vs United States Over the Years
Count of Oncology Trials Starting in the Next 3 Months
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Top 10 Recent Clinical Trials by Completion Date